Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering best-in-class drug treatments and product support to the underserved rare disease patient community. We focus on rare metabolic and neurological genetic conditions. Our patients typically require life-long treatment with life-saving medicine.
Frequent and forever drug treatment can significantly impact the quality-of-life of patients. It can also impact the lives of their families and other caregivers. Cycle's approach is to utilize the latest cutting-edge pharmaceutical technologies to deliver the required medicine, with the minimum impact on daily routines.
Just as importantly, Cycle is commited to provide product support to patients, families, caregivers and the healthcare provider community.